Tamás Ferenci (T Ferenci)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 15

Top Venues

Nutrients

Journal of personalized medicine

European journal of epidemiology

Expert opinion on biological therapy

Óbuda University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Óbuda University Sep 01 2013

Hungary

assistant lecturer :: Physiological Controls Research Center

Publications

Judith Rittenschober-Böhm, Johanna Strassl, Maria Kletecka-Pulker, Péter Szerémy, Tamás Haidegger, Tamás Ferenci, Angelika Berger, Michael Wagner
Evaluation of a Video-Based Concept for Hand Hygiene Education of Parents in a Neonatal Intensive Care Unit. Healthcare (Basel, Switzerland) 12 (17) (2024)
Tamás Ferenci
Comparing methods to predict baseline mortality for excess mortality calculations. BMC medical research methodology 23 (1) (2023)
Noemi Bora, Orsolya Balogh, Tamás Ferenci, Zsolt Piróth
Functional Assessment of Long-Term Microvascular Cardiac Allograft Vasculopathy. Journal of personalized medicine 13 (12) (2023)
Noemi Bora, Orsolya Balogh, Tamás Ferenci, Zsolt Piróth
Functional Assessment of Long-Term Microvascular Cardiac Allograft Vasculopathy. Journal of personalized medicine 13 (12) (2023)
Éva Szabó, Ildikó Csölle, Regina Felső, Daniela Kuellenberg de Gaudry, Patrick Nyamemba Nyakundi, Kazahyet Ibrahim, Maria-Inti Metzendorf, Tamás Ferenci, Szimonetta Lohner
Benefits and Harms of Edible Vegetable Oils and Fats Fortified with Vitamins A and D as a Public Health Intervention in the General Population: A Systematic Review of Interventions. Nutrients 15 (24) (2023)
Éva Szabó, Ildikó Csölle, Regina Felső, Daniela Kuellenberg de Gaudry, Patrick Nyamemba Nyakundi, Kazahyet Ibrahim, Maria-Inti Metzendorf, Tamás Ferenci, Szimonetta Lohner
Benefits and Harms of Edible Vegetable Oils and Fats Fortified with Vitamins A and D as a Public Health Intervention in the General Population: A Systematic Review of Interventions. Nutrients 15 (24) (2023)
Zsombor Zrubka, Áron Kincses, Tamás Ferenci, Levente Kovacs, László Gulácsi, Márta Péntek
Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary. PloS one 17 (3) (2022)
Tamás Ferenci
The Author Replies. European journal of epidemiology 37 (2) (2022)
Sándor Szépkúti, Szilvia Bandur, Gábor Kovács, Tamás Ferenci, Márk M Svébis, Piroska Turbucz, Ádám Gy Tabák
Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study. BMC endocrine disorders 22 (1) (2022)
Zsolt Piróth, Hisao Otsuki, Frederik M Zimmermann, Tamás Ferenci, Danielle C J Keulards, Alan C Yeung, Nico H J Pijls, Bernard de Bruyne, William F Fearon
Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial. Circulation. Cardiovascular interventions 15 (11) (2022)
Tamás Ferenci
Different approaches to quantify years of life lost from COVID-19. European journal of epidemiology 36 (6) (2021)
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Csontos, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas
Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert opinion on biological therapy 21 (4) (2021)
Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Csontos, Anna Fábián, Kata Szántó, Zsuzsanna Végh, Zsuzsanna Kürti, Péter L Lakatos, Zoltán Szepes, Tamás Molnár
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center. Expert opinion on biological therapy 17 (11) (2017)
G Bencskó, Tamás Ferenci
Effective case/infection ratio of poliomyelitis in vaccinated populations. Epidemiology and infection 144 (9) (2016)
Tamás Ferenci
Absolute risk reduction may depend on the duration of the follow-up. Expert review of clinical pharmacology 10 (12) (2015)

Tamás Ferenci.css-eqlu8i{font-size:small;padding-left:4px;} (T Ferenci)

Publication Activity (10 Years)

Top Topics

Top Venues

Tamás Ferenci (T Ferenci)